pharma · Cervical Cancer · Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical
Sichuan Baili Pharmaceutical Co.,
Sichuan Baili Pharmaceutical drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 4
- Drugs
- 0
- Patents
- 0
Sichuan Baili Pharmaceutical pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Sichuan Baili Pharmaceutical drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.